-- South Korean biopharmaceutical company Celltrion (KRX:068270) plans to retire 488,983 treasury shares, valued at 100 billion won, according to a Wednesday filing with the Korea Exchange.
The shares will be retired on May 21 at a par value of 1,000 won apiece.